Rahul Agrawal

CMO and Head of R&D at Cereno Scientific

Speaker

Rahul Agrawal, MD, MBA, (UK), FESC, is Chief Medical Officer and Head of R&D at Cereno Scientific, a pioneering biotech developing innovative therapies for rare cardiovascular and pulmonary diseases. He is an accomplished senior executive with over 20 years of experience across Big Pharma and biotech, spanning the full value chain from R&D and Medical Affairs to strategy and commercialization. Rahul has played a central role in the global launch of seven drugs and has extensive expertise in cardiovascular, renal, respiratory, and rare/orphan diseases. His career includes senior leadership positions as CMO at Cardior, VP and Global Medicines Leader at AstraZeneca, and Global Director of Medical Affairs and Clinical Development at Bayer HealthCare. Rahul holds an MD degree from the Free University of Berlin and Cornell University and is board-certified in cardiology, internal medicine, and emergency medicine. He also holds an MBA from Buckinghamshire New University, UK.